{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:59Z","timestamp":1740107639160,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T00:00:00Z","timestamp":1440028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00467-015-3166-7","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T01:45:32Z","timestamp":1439948732000},"page":"2129-2134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel factor H mutation associated with familial membranoproliferative glomerulonephritis type I"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-0869","authenticated-orcid":false,"given":"Hadas","family":"Alfandary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Davidovits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,20]]},"reference":[{"key":"3166_CR1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1046\/j.1523-1755.1999.00408.x","volume":"55","author":"M Bonilla-Felix","year":"1999","unstructured":"Bonilla-Felix M, Parra C, Dajani T, Ferris M, Swinford RD, Portman RJ, Verani R (1999) Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int 55:1885\u20131890","journal-title":"Kidney Int"},{"key":"3166_CR2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","volume":"338","author":"SR Orth","year":"1998","unstructured":"Orth SR, Ritz E (1998) The nephrotic syndrome. N Engl J Med 338:1202\u20131211","journal-title":"N Engl J Med"},{"key":"3166_CR3","first-page":"194","volume":"1","author":"R Habib","year":"1973","unstructured":"Habib R, Kleinknechet C, Gubler MC, Levy M (1973) Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol 1:194\u2013214","journal-title":"Clin Nephrol"},{"key":"3166_CR4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","volume":"366","author":"S Sethi","year":"2012","unstructured":"Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis\u2014a new look at an old entity. N Engl J Med 366:1119\u20131131","journal-title":"N Engl J Med"},{"key":"3166_CR5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","volume":"84","author":"MC Pickering","year":"2013","unstructured":"Pickering MC, D\u2019Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Fr\u00e9meaux-Bacchi V, Gale DP, Goicoechea de Jorge E, Griffin G, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Paul Morgan B, Nast CC, Noel LH, Peters DK, Rodr\u00edguez de C\u00f3rdoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT (2013) C3 glomerulopathy: consensus report. Kidney Int 84:1079\u20131089","journal-title":"Kidney Int"},{"key":"3166_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","volume":"44","author":"A Servias","year":"2007","unstructured":"Servias A, Fremeaux Bacchi V, Lequinterc M, Salomon R, Blouin J, Knebelmann B, Gr\u00fcnfeld JP, Lesavre P, No\u00ebl LH, Fakhouri F (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with hemolytic uraemic syndrome. J Med Genet 44:193\u2013199","journal-title":"J Med Genet"},{"key":"3166_CR7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1034\/j.1399-3038.2001.012003166.x","volume":"12","author":"R Schwartz","year":"2001","unstructured":"Schwartz R, Rother U, Ander D, Gretz N, Scharer K, Kirshfink M (2001) Complement analysis in children with idiopathic membranoproliferative GN: a long-term follow up. Pediatr Allergy Immunol 12:166\u2013172","journal-title":"Pediatr Allergy Immunol"},{"key":"3166_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2215\/CJN.03480708","volume":"4","author":"SH Nasr","year":"2009","unstructured":"Nasr SH, Valeri AM, Appel GB, Sherwinter J, Stokes MB, Said SM, Markowitz GS, D'Agati VD (2009) Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol 4:22\u201332","journal-title":"Clin J Am Soc Nephrol"},{"key":"3166_CR9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","volume":"82","author":"A Servais","year":"2012","unstructured":"Servais A, Noel AH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Gr\u00fcnfeld JP, Niaudet P, Lesavre P, Fr\u00e9meaux-Bacchi V (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82:454\u2013464","journal-title":"Kidney Int"},{"key":"3166_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00467-010-1734-4","volume":"26","author":"V Leroy","year":"2011","unstructured":"Leroy V, Fremeaux-Bacchi V, Peuchmaur M, Baudouin V, Desch\u00eanes G, Macher MA, Loirat C (2011) Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation. Pediatr Nephrol 26:419\u2013424","journal-title":"Pediatr Nephrol"},{"key":"3166_CR11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.ki.5000155","volume":"69","author":"F Vaziri Sani","year":"2006","unstructured":"Vaziri Sani F, Holmberg L, Sjoholm AG, Kristofferrson AC, Manea M, Fremeaux Bacchi V, Ferhrman Ekholm I, Raafat R, Karpman D (2006) Phenorypic expression of factor H mutations in patients with atypical HUS. Kidney Int 69:981\u2013988","journal-title":"Kidney Int"},{"key":"3166_CR12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","volume":"15","author":"MA Dragon-Durey","year":"2004","unstructured":"Dragon-Durey MA, Fr\u00e9meaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G, Coppo P, Herman Fridman W, Weiss L (2004) Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol 15:787\u2013795","journal-title":"J Am Soc Nephrol"},{"key":"3166_CR13","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJMc1106619","volume":"366","author":"S Radhakrishnan","year":"2012","unstructured":"Radhakrishnan S, Lunn A, Kirshfink M, Thorner P, Hebert D, Langlois V, Pluthero F, Licht C (2012) Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med 366:1165\u20131166","journal-title":"N Engl J Med"},{"key":"3166_CR14","first-page":"811","volume":"9","author":"V Fr\u00e9meaux-Bacchi","year":"1994","unstructured":"Fr\u00e9meaux-Bacchi V, Weiss L, Brun P, Kazatchkine MD (1994) Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation. Nephrol Dial Transplant 9:811\u2013814","journal-title":"Nephrol Dial Transplant"},{"key":"3166_CR15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"RF Zipfel","year":"2009","unstructured":"Zipfel RF, Skerka C (2009) Complement regulators and inhibitory protein. Nat Rev Immunol 9:729\u2013740","journal-title":"Nat Rev Immunol"},{"key":"3166_CR16","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G (2009) Atypical hemolytic uremic syndrome. N Engl J Med 361:1676\u20131687","journal-title":"N Engl J Med"},{"key":"3166_CR17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.05.009","volume":"52","author":"TH Goodship","year":"2012","unstructured":"Goodship TH, Pappworth IY, Toth T, Denton M, Houlberg K, McCormick F, Warland D, Moore I, Hunze EM, Staniforth SJ, Hayes C, Cavalcante DP, Kavanagh D, Strain L, Herbert AP, Schmidt CQ, Barlow PN, Harris CL, Marchbank KJ (2012) Factor H autoantibodies in membranoproliferative glomerulonephritis. Mol Immunol 52:200\u2013206","journal-title":"Mol Immunol"},{"key":"3166_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s004670050241","volume":"11","author":"DG Williams","year":"1997","unstructured":"Williams DG (1997) C3 nephritic factor and mesangiocapillary glomerulonephritis. Pediatr Nephrol 11:96\u201398","journal-title":"Pediatr Nephrol"},{"key":"3166_CR19","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1681\/ASN.2005010078","volume":"16","author":"GB Appel","year":"2005","unstructured":"Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16:1392\u20131403","journal-title":"J Am Soc Nephrol"},{"key":"3166_CR20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MNH.0b013e328345848b","volume":"20","author":"MC Pickering","year":"2011","unstructured":"Pickering MC, Cook HT (2011) Complement and glomerular disease: new insights. Curr Opin Nephrol Hypertens 20:271\u2013277","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3166_CR21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1681\/ASN.2006020138","volume":"17","author":"JJ Alexander","year":"2006","unstructured":"Alexander JJ, Aneziokoro OGB, Chang A, Hack BK, Markaryan A, Jacob A, Luo R, Thirman M, Haas M, Quigg RJ (2006) Distinct and separable roles of the complement system in factor H deficient bone marrow chimeric mice with immune complex disease. J Am Soc Nephrol 17:1354\u20131361","journal-title":"J Am Soc Nephrol"},{"key":"3166_CR22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1681\/ASN.2004090778","volume":"16","author":"JJ Alexander","year":"2005","unstructured":"Alexander JJ, Pickering MC, Hass M, Osawe I, Quigg RJ (2005) Complement factor H limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness. J Am Soc Nephrol 16:52\u201357","journal-title":"J Am Soc Nephrol"},{"key":"3166_CR23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1681\/ASN.2006101125","volume":"18","author":"JJ Alexander","year":"2007","unstructured":"Alexander JJ, Wang Y, Chang A, Jacob A, Minto AW, Karmegam M, Haas M, Quigg RJ (2007) Mouse podocyte complement facto H: the functional analogue to human complement receptor 1. J Am Soc Nephrol 18:1157\u20131166","journal-title":"J Am Soc Nephrol"},{"key":"3166_CR24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1681\/ASN.2010060647","volume":"22","author":"B Lihua","year":"2011","unstructured":"Lihua B, Haas M, Quigg RJ (2011) Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol 22:285\u2013295","journal-title":"J Am Soc Nephrol"},{"key":"3166_CR25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00467-010-1719-3","volume":"26","author":"AL Lapeyraque","year":"2011","unstructured":"Lapeyraque AL, Fremeaux-Bacci V, Robitallie P (2011) Efficacy of eculizumab in patient with factor H associated atypical hemolytic uremic syndrome. Pediatr Nephrol 26:621\u2013624","journal-title":"Pediatr Nephrol"},{"key":"3166_CR26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMc0809959","volume":"360","author":"RA Gruppo","year":"2009","unstructured":"Gruppo RA, Rother RP (2009) Eculizumab for congenital atypical hemolytic uremic syndrome. N Engl J Med 360:544\u2013546","journal-title":"N Engl J Med"},{"key":"3166_CR27","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMc1112273","volume":"366","author":"E Daina","year":"2012","unstructured":"Daina E, Noris M, Remuzzi G (2012) Eculizumab in patient with dense deposit disease. N Engl J Med 366:1161\u20131163","journal-title":"N Engl J Med"},{"key":"3166_CR28","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMc1111953","volume":"366","author":"M Vivarelli","year":"2012","unstructured":"Vivarelli M, Pasini A, Emma F (2012) Eculizumab for the treatment of dense-deposit disease. N Engl J Med 366:1163\u20131165","journal-title":"N Engl J Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3166-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-015-3166-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3166-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T11:13:47Z","timestamp":1567077227000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-015-3166-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,20]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["3166"],"URL":"https:\/\/doi.org\/10.1007\/s00467-015-3166-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2015,8,20]]}}}